Ira M Jacobson
Overview
Explore the profile of Ira M Jacobson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
175
Citations
10440
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Block T, Guo J, Zoulim F, Rice C, Thio C, Schneider W, et al.
Nat Rev Gastroenterol Hepatol
. 2025 Feb;
22(3):150-151.
PMID: 39910374
No abstract available.
2.
Tu T, McQuaid T, Jacobson I
Liver Int
. 2024 Dec;
45(1):e16202.
PMID: 39720865
Background: Chronic hepatitis B virus (HBV) infection is a common but underdiagnosed and undertreated health condition and is the leading cause of hepatocellular carcinoma (HCC) worldwide. HBV (rated a Grade...
3.
de Jong Y, Jacobson I
J Viral Hepat
. 2024 Apr;
31 Suppl 1:35-40.
PMID: 38606953
Hepatocellular carcinoma (HCC) has long been recognized as a complication in people with chronic liver disease, particularly those with cirrhosis. Two gene therapies for haemophilia A and B recently approved...
4.
Yuen M, Fung S, Ma X, Nguyen T, Hassanein T, Hann H, et al.
JHEP Rep
. 2024 Mar;
6(4):100999.
PMID: 38510983
Background & Aims: The investigational first-generation core inhibitor vebicorvir (VBR) demonstrated safety and antiviral activity over 24 weeks in two phase IIa studies in patients with chronic HBV infection. In...
5.
Jacobson I
Gastroenterol Hepatol (N Y)
. 2024 Feb;
20(2):123-126.
PMID: 38414910
No abstract available.
6.
Gish R, Jacobson I, Lim J, Waters-Banker C, Kaushik A, Kim C, et al.
Hepatology
. 2023 Nov;
79(5):1117-1128.
PMID: 37976395
Background And Aims: HDV leads to the most severe form of viral hepatitis; however, the prevalence of HDV is not well understood. Using real-world data from the All-Payer Claims Database,...
7.
Su F, Jacobson I
Clin Liver Dis
. 2023 Oct;
27(4):791-808.
PMID: 37778770
The main aim of antiviral therapy in patients with chronic hepatitis B (CHB) is to prevent disease progression and reduce the risk of hepatocellular carcinoma (HCC). In general, treatment is...
8.
Pan C, Gish R, Jacobson I, Hu K, Wedemeyer H, Martin P
Dig Dis Sci
. 2023 Aug;
68(10):4062-4063.
PMID: 37558801
No abstract available.
9.
Yuen M, Asselah T, Jacobson I, Brunetto M, Janssen H, Takehara T, et al.
Lancet Gastroenterol Hepatol
. 2023 Jul;
8(9):790-802.
PMID: 37442152
Background: JNJ-73763989 (JNJ-3989), a small interfering RNA, targets all hepatitis B virus (HBV) RNAs, reducing all HBV proteins. JNJ-56136379 (JNJ-6379; also known as bersacapavir), a capsid assembly modulator, inhibits HBV...
10.
Pan C, Gish R, Jacobson I, Hu K, Wedemeyer H, Martin P
Dig Dis Sci
. 2023 Jun;
68(8):3237-3248.
PMID: 37338616
Hepatitis D virus (HDV) depends on hepatitis B virus (HBV) to enter and exit hepatocytes and to replicate. Despite this dependency, HDV can cause severe liver disease. HDV accelerates liver...